Skip to main content

Table 3 Outcome indicators employed in the literature to assess clinical inertia

From: Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review

 

References

Percentage of patients with HbA1c < 7%

[83]

Time required to reach targets of HbA1c, sBP and LDL cholesterol

[87]

Comparison between personalized HbA1c target and actual HbA1c levels

[73]

Percentage of patients who do not achieve the individualized targets

[90]

Life expectancy and economic burden associated with diabetes-related complications in populations reaching different targets of HbA1c, in a series of models of delayed therapy intensification e and across a range of time horizons

[91]

Median time to the progression of diabetic retinopathy

[92]

Incidence rate of diabetic retinopathy progression in presence or absence of clinical inertia (lack of initiation of insulin therapy within 3 months from a report of HBA1c > 9%)

[92]